trending Market Intelligence /marketintelligence/en/news-insights/trending/7tomf-halxj0wr1qvwwnwq2 content esgSubNav
In This List

Biotricity launches remote heart monitoring device

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Biotricity launches remote heart monitoring device

Biotricity Inc. launched its mobile cardiac monitoring and diagnosis system Bioflux.

The medical device consists of a mobile electrocardiography, or ECG, monitoring device and an ECG viewer software package that enables physicians to remotely monitor and diagnose patients in real time.

Bioflux received 510(k) clearance from the U.S. Food and Drug Administration in December 2017.